A mixed meal tolerance test predicts onset of type 2 diabetes in Southwestern Indigenous adults.


Journal

Nutrition & diabetes
ISSN: 2044-4052
Titre abrégé: Nutr Diabetes
Pays: England
ID NLM: 101566341

Informations de publication

Date de publication:
10 Jul 2024
Historique:
received: 05 05 2023
accepted: 23 02 2024
revised: 05 01 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 10 7 2024
Statut: epublish

Résumé

To identify predictors of incident type 2 diabetes using a mixed meal tolerance test (MMTT). Adult Indigenous Americans without diabetes (n = 501) from a longitudinal cohort underwent at baseline a 4-h MMTT, measures of body composition, an oral glucose tolerance test, an intravenous glucose tolerance test for acute insulin response (AIR), and a hyperinsulinemic-euglycemic clamp for insulin action (M). Plasma glucose responses from the MMTT were quantified by the total and incremental area under the curve (AUC/iAUC). At follow-up (median time 9.6 [inter-quartile range: 5.6-13.5] years), 169 participants were diagnosed with diabetes. Unadjusted Cox proportional hazards models, glucose AUC Glucose responses to a mixed meal predicted the development of type 2 diabetes. This indicates that a mixed nutritional challenge provides important information on disease risk. ClinicalTrials.gov identifier : NCT00340132, NCT00339482.

Sections du résumé

BACKGROUND/OBJECTIVE OBJECTIVE
To identify predictors of incident type 2 diabetes using a mixed meal tolerance test (MMTT).
METHODS METHODS
Adult Indigenous Americans without diabetes (n = 501) from a longitudinal cohort underwent at baseline a 4-h MMTT, measures of body composition, an oral glucose tolerance test, an intravenous glucose tolerance test for acute insulin response (AIR), and a hyperinsulinemic-euglycemic clamp for insulin action (M). Plasma glucose responses from the MMTT were quantified by the total and incremental area under the curve (AUC/iAUC).
RESULTS RESULTS
At follow-up (median time 9.6 [inter-quartile range: 5.6-13.5] years), 169 participants were diagnosed with diabetes. Unadjusted Cox proportional hazards models, glucose AUC
CONCLUSIONS CONCLUSIONS
Glucose responses to a mixed meal predicted the development of type 2 diabetes. This indicates that a mixed nutritional challenge provides important information on disease risk.
CLINICAL TRIAL REGISTRY BACKGROUND
ClinicalTrials.gov identifier : NCT00340132, NCT00339482.

Identifiants

pubmed: 38987291
doi: 10.1038/s41387-024-00269-3
pii: 10.1038/s41387-024-00269-3
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Banques de données

ClinicalTrials.gov
['NCT00339482', 'NCT00340132']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50

Informations de copyright

© 2024. The Author(s).

Références

Centers for Disease Control and Prevention. National Diabetes Statistics Report website. [Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html .
Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, et al. The prevention of type 2 diabetes. Nat Clin Pr Endocrinol Metab. 2008;4:382–93.
doi: 10.1038/ncpendmet0843
Stroeve JHM, van Wietmarschen H, Kremer BHA, van Ommen B, Wopereis S. Phenotypic flexibility as a measure of health: the optimal nutritional stress response test. Genes Nutr. 2015;10:13.
doi: 10.1007/s12263-015-0459-1 pubmed: 25896408 pmcid: 4404421
Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized NUtrition By Prediction Of Glycemic Responses. Cell. 2015;163:1079–94.
doi: 10.1016/j.cell.2015.11.001 pubmed: 26590418
Berry SE, Valdes AM, Drew DA, Asnicar F, Mazidi M, Wolf J, et al. Publisher correction: human postprandial responses to food and potential for precision nutrition. Nat Med. 2020;26:1802.
doi: 10.1038/s41591-020-1130-y pubmed: 33082577
Nuttall FQGM, Wald JL, Ahmed M. Plasma glucose and insulin profiles in normal subjects ingresting diets of varying carbohydrate, fat and protein content. J Am Coll Nutr. 1985;4:437–50.
doi: 10.1080/07315724.1985.10720086 pubmed: 3900180
Nuttall F, Mooradian AD, Gannon MC, Billington CJ, Krezowski P. Effect of protein ingestion on the gluose and insulin response to a standardized oral glucose load. Diabetes Care. 1984;7:465–70.
doi: 10.2337/diacare.7.5.465 pubmed: 6389060
Denis McGarry J. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7–18.
pubmed: 11756317
Shankar SS, Vella A, Raymond RH, Staten MA, Calle RA, Bergman RN, et al. Standardized mixed-meal tolerance and arginine stimulation tests provide reproducible and complementary measures of beta-cell function: Results from the foundation for the National Institutes of Health Biomarkers Consortium investigative series. Diabetes Care. 2016;39:1602–13.
doi: 10.2337/dc15-0931 pubmed: 27407117 pmcid: 5001146
Lages M, Barros R, Moreira P, Guarino MP. Metabolic Effects of an Oral Glucose Tolerance Test Compared to the Mixed Meal Tolerance Tests: A Narrative Review. Nutrients. 2022;14:2032.
doi: 10.3390/nu14102032 pubmed: 35631171 pmcid: 9147413
Department of Health and Human Services. Nutrition for Precision Health 2021 [Available from: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-005.html .
Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol. 1978;108:497–505.
doi: 10.1093/oxfordjournals.aje.a112648 pubmed: 736028
Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl J Med. 1993;329:1988–92.
doi: 10.1056/NEJM199312303292703 pubmed: 8247074
Paddock E, Hohenadel MG, Piaggi P, Vijayakumar P, Hanson RL, Knowler WC, et al. One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans. Diabetologia. 2017;60:1704–11.
doi: 10.1007/s00125-017-4332-1 pubmed: 28664298 pmcid: 6476564
Shah MH, Piaggi P, Looker HC, Paddock E, Krakoff J, Chang DC. Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans. Diabetologia. 2021;64:914–22.
doi: 10.1007/s00125-020-05348-5 pubmed: 33404681
Ferraro R, Boyce VL, Swinburn B, De Gregorio M, Ravussin E. Energy cost of physical activity on a metabolic ward in relationship to obesity. Am J Clin Nutr. 1991;53:1368–71.
doi: 10.1093/ajcn/53.6.1368 pubmed: 2035463
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7.
doi: 10.2337/diacare.26.11.3160 pubmed: 14578255
Tataranni PA, Ravussin E. Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr. 1995;62:730–4.
doi: 10.1093/ajcn/62.4.730 pubmed: 7572700
Guo Y, Franks PW, Brookshire T, Antonio Tataranni P. The intra- and inter-instrument reliability of DXA based on ex vivo soft tissue measurements. Obes Res. 2004;12:1925–9.
doi: 10.1038/oby.2004.241 pubmed: 15687392
Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest. 1984;74:1238–46.
doi: 10.1172/JCI111533 pubmed: 6384267 pmcid: 425290
Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C. Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab. 1995;80:1571–6.
pubmed: 7745002
Alferes VR, Alferes VR. Methods of randomization in experimental design. Los Angeles: SAGE; 2012.
Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N. Engl J Med. 1988;318:1217–25.
doi: 10.1056/NEJM198805123181901 pubmed: 3283552
Ravussin E, Bogardus C. Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr. 1989;49:968–75.
doi: 10.1093/ajcn/49.5.968 pubmed: 2655422
Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care. 2009;32:335–41.
doi: 10.2337/dc08-1478 pubmed: 18957530 pmcid: 2628704
Pencina MJ, D’Agostino RB Sr. Evaluating discrimination of risk prediction models: The c statistic. JAMA. 2015;314:1063–4.
doi: 10.1001/jama.2015.11082 pubmed: 26348755
Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109–23.
doi: 10.1002/sim.1802 pubmed: 15211606
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the are under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.
doi: 10.2307/2531595 pubmed: 3203132
Wopereis S, Stroeve JHM, Stafleu A, Bakker GCM, Burggraaf J, van Erk MJ, et al. Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge. Genes Nutr. 2017;12:21.
doi: 10.1186/s12263-017-0570-6 pubmed: 28861127 pmcid: 5576306
Caumo A, Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab. 2000;85:4396–402.
doi: 10.1210/jcem.85.11.6982 pubmed: 11095485

Auteurs

Cassie M Mitchell (CM)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA. cassie-mitchell@ouhsc.edu.
Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA. cassie-mitchell@ouhsc.edu.

Emma J Stinson (EJ)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.

Douglas C Chang (DC)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.

Jonathan Krakoff (J)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH